Search PubMed⌕ Search

Biomedical subjects

K M Schwartz

Publications and source records attributed to K M Schwartz.

16 recordsLinked to original sources

Pattern of T2 hypointensity associated with ring-enhancing brain lesions can help to differentiate pathology.

Ring-enhancing lesions seen on MR images can occur with a variety of etiologies. Some ring-enhancing lesions have hypointense rims peripherally on T2-weighted MR images. In this study, we examined whether T2 hypointense rims were associated with specific pathologies. A search for ring-enhancing lesions on MR images obtained from 1996 to 2004 was performed, and revealed 221 patients with MRI findings of ring enhancement. The pattern of T2 hypointensity (arc or rim) corresponding with ring enhancement was recorded. In addition, we analyzed other imaging characteristics, including signal on diffusion-weighted images, central homogeneity on T2 and multiplicity of lesions. We then reviewed clinical data on the patients to ascertain the diagnosis for each examination. The most common associated pathologies in our study were gliomas (40%), metastases (30%), abscesses (8%) and multiple sclerosis (MS; 6%). Hypointense borders on T2-weighted images were present in 67% of lesions in the form of a rim in 40% and an arc in 60%. Abscesses had the highest percentage of hypointense rims. Metastases and gliomas more commonly had arcs, and MS lesions were divided between rims and arcs. Abscesses and MS lesions were more commonly homogeneous centrally, compared to gliomas and metastases. Additionally, abscesses were more often bright on diffusion imaging than the other pathologies. As expected, abscesses and MS lesions were usually multiple, whereas metastases were typically multiple in approximately 50% of the patients; gliomas were generally solitary. Trends in T2 hypointensity may aid in distinguishing among etiologies of ring-enhancing lesions, although there is overlap between the MR appearance of these various pathologies.

Brain↗

Pseudotumor of infancy and congenital muscular torticollis: 170 cases.

OBJECTIVES: To review pseudotumor of infancy (POI) and congenital muscular torticollis (CMT) and to suggest an algorithm for treatment. STUDY DESIGN: Retrospective review of cases from 1962 to 1998 at a tertiary care center. METHODS: Patients included in this study were 81 boys and 89 girls who had a diagnosis of POI (n = 38) or CMT (n = 132) before 24 months of age. RESULTS: For all patients, the mean age at diagnosis was 4 months; 54.1% had the left side of the neck affected, over 90% had a head tilt, and 2.4% had feeding difficulty as a result of the disorder. Plagiocephaly was present in 39.5% of patients with POI and 63.6% of patients with CMT; a neck mass, in 63.2% and 18.2%, respectively; and facial asymmetry, in 7.9% and 15.9%, respectively. All patients had a complete physical examination; 54.1% had plain cervical radiography, 4.1%, computed tomography, and 2.9%, ultrasonography. Passive range of motion was the initial treatment recommended for 65.3% of patients. Conservative treatment failed for 16 patients; subsequently, they had surgical treatment. Follow-up data were available for 159 patients; 85.5% experienced total resolution and 14.5% experienced subtotal resolution or long-term abnormality. CONCLUSIONS: Children diagnosed with POI or CMT should be treated and observed for at least 12 months or until symptoms resolve. If symptoms persist 1 year after diagnosis despite conservative therapy, surgical treatment should be considered. The majority of children with POI or CMT experience total resolution of symptoms.

Algorithms↗

Effects of oral propafenone on defibrillation and pacing thresholds in patients receiving implantable cardioverter-defibrillators. Propafenone Defibrillation Threshold Investigators.

OBJECTIVES: The effects of propafenone, a predominantly class IC antiarrhythmic drug, on defibrillation and pacing thresholds were evaluated in patients undergoing cardioverter-defibrillator implantation. BACKGROUND: Previous studies have shown that the class IC agents encainide and flecainide may increase the energy requirements for pacing and defibrillation. Animal studies with propafenone have shown inconsistent results regarding its effect on defibrillation energy requirements. This report investigated the effects of propafenone on defibrillation and pacing thresholds in humans. METHODS: After cardioverter-defibrillator implantation, 47 patients were enrolled in a double-blind, three-way parallel, randomized trial of 450 mg/day (Group 1) or 675 mg/day (Group 2) of oral propafenone or placebo (Group 3) for 3 to 7 days. Predischarge defibrillation and pacing thresholds after treatment were compared with baseline thresholds obtained at implantation. RESULTS: There was no statistically significant difference between implantation and predischarge defibrillation thresholds in the three groups (Group 1: [mean +/- SE] 11.0 +/- 1.3 vs. 12.1 +/- 1.5 J; Group 2: 11.5 +/- 1.1 vs. 13.6 +/- 1.3 J; Group 3: 12.5 +/- 1.2 vs. 13.3 +/- 1.6 J), and no significant difference between treatment groups was found with a 0.86 power to detect a 5-J difference between groups. Paired pulse width pacing thresholds at 2.8 V were compared in 14 patients. A small increase of 0.02 ms was noted at predischarge testing in patients treated with propafenone and placebo. CONCLUSIONS: Short-term oral propafenone (450 and 675 mg/day) does not significantly affect defibrillation or pacing thresholds. Concomitant use of propafenone in patients with implantable cardioverter-defibrillators with recurrent ventricular or atrial tachyarrhythmias should not interfere with proper device function.

Administration, Oral↗

Production of IL2 and IL3 in syngeneic mixed lymphocyte reactions of BALB/c mice are elevated during a period of moderate dietary protein deficiency.

The mixed lymphocyte reaction (MLR) is a model of T cell responsiveness to antigenic peptides complexed with major histocompatibility (MHC) proteins on antigen presenting cells (APC). Since dietary protein deficiencies alter T cell development, syngeneic and allogeneic MLR were investigated in mice fed a low protein 4% casein (4Ca) or control 20% casein (20Ca) diet. Proliferation of splenic lymphocyte populations from BALB/c mice fed 4Ca was increased during syngeneic and allogeneic MLR compared with lymphocytes from mice fed 20Ca. Increased proliferation was accompanied by significantly higher production of IL2 and IL3 during syngeneic, but not allogeneic MLR. To determine the influence of autologous B cells on IL2 and IL3 production during MLR, lymphocyte populations of mice fed 4Ca or 20Ca were depleted of B cells. Splenic lymphocyte populations of mice fed 4Ca that were depleted of B cells did not exhibit increased IL2 or IL3 production during syngeneic or allogeneic MLR. Splenic APc of mice given 4Ca caused greater proliferation during MLR. However, APC of 4Ca mice did not cause greater IL2 or IL3 production. Similarly neither IgM-B cells nor macrophage from mice fed 4Ca induced elevated IL2 or IL3 production during syngeneic or allogeneic MLR. A dichotomy appeared in that 4Ca-APC were able to induce higher T cell proliferation but not cytokine production compared with 20Ca-APC. The enhancement of T cell responsiveness to Class II MHC determinants on APC during moderate protein deficiency appears to require both T and B cells from mice fed the deficient diet.

Animals↗

Experience with the use of coronary autoperfusion catheter during complicated angioplasty.

Between February and July of 1989, 22 patients underwent the use of the Stack autoperfusion catheter following acute occlusion or obstructive dissection during coronary angioplasty; in 20 cases conventional balloon was used in an attempt to correct the angiographic appearance followed by the use of Stack catheter when results were sub-optimal. Only 1 patient (4.5%) required surgical revascularization. Although our study is not prospective or randomized, our observations suggest a significant impact in decreasing the need for emergency surgical revascularization after complicated coronary angioplasty with the use of this approach.

Adult↗

Atenolol and chlorthalidone therapy for hypertension: a double-blind comparison.

In a randomized, double-blind, parallel-group study of 31 patients with mild to moderate hypertension, we compared a placebo regimen with a regimen of atenolol and chlorthalidone (Tenoretic). The study, which lasted seven weeks, began with a single-blind two-week placebo lead-in period, followed by a four-week double-blind treatment phase, and concluded with a one-week single-blind placebo washout period. Of 24 patients included in the analysis of efficacy, seven received one Tenoretic 50 tablet per day (atenolol, 50 mg; chlorthalidone, 25 mg), nine received one Tenoretic 100 tablet per day (atenolol, 100 mg; chlorthalidone, 25 mg), and eight received placebo. Supine systolic/diastolic blood pressure (mean +/- SD) decreased from 154 +/- 15.2/102 +/- 4.6 mm Hg during the baseline period to 128 +/- 8.5/85 +/- 4.0 mm Hg during treatment in the group receiving Tenoretic 100, from 153 +/- 12.6/104 +/- 5.4 mm Hg to 137 +/- 4.5/91 +/- 4.4 mm Hg in the group receiving Tenoretic 50, and from 150 +/- 11.9/101 +/- 1.6 mm Hg to 145 +/- 11.6/93 +/- 5.1 mm Hg in the group receiving placebo. Reductions in systolic and diastolic blood pressures in the active treatment groups were significantly greater than the pressure reductions in the group receiving placebo (P less than .05 to .1). The combination of atenolol and chlorthalidone was well tolerated, and in no case was treatment discontinued because of side effects. This study showed that one tablet per day of either Tenoretic 50 or Tenoretic 100 is effective and well tolerated in the treatment of mild to moderate hypertension.

Adult↗

A temporary external DDD pacing unit.

A device for temporary external DDD pacing was developed using a modified permanent pulse generator, and temporary atrial and ventricular electrode catheters were inserted pervenously. The atrial lead was a J type and the ventricular lead had a remote anode in the superior vena cava. With a special clamp and appropriate connectors the permanent DDD pulse generator provided unipolar external DDD pacing. The device was evaluated in 13 patients to control bradyarrhythmias or for overdrive pacing in an attempt to control tachyarrhythmias. Nine patients were ambulatory; all had continuous electrocardiographic monitoring. The device was used for 1 to 12 days (mean 4.9). Eight patients benefited from temporary DDD pacing and 7 had permanent DDD pacemakers implanted. In 1 patient, atrial fibrillation developed, 2 patients had brief episodes of ventricular lead displacement and another required reprogramming because of loss of ventricular capture. Results suggest that the device is applicable for a clinical trial of DDD pacing before possible permanent implantation when attempting to improve cardiac output or control arrhythmias.

Aged↗

Clinical evaluation of a new temporary atrial pacing catheter: results in 100 patients.

Absence of a temporary atrial electrode that is stable and easily positioned has limited the use of atrial pacing in the hospital setting. A novel electrode involving a performed, 6F "J"-shaped catheter with a 10F anodal sphere and proximal fixed orienting wings 28 cm from the anodal tip was constructed. This design facilitated percutaneous insertion into the subclavian vein and positioning without fluoroscopy. Over a 15-month period, five physicians used the device in 100 patients for control of bradycardia in 56, overdrive suppression of atrial or ventricular tachyarrhythmias in 29, conversion and control of paroxysmal atrial tachycardia in seven, and temporary atrial-ventricular sequential pacing in eight patients with complete heart block. In 75 patients the electrode was inserted at the bedside without the benefit of fluoroscopy. Average insertion time was 2.5 minutes, initial thresholds were good, and lead stability evaluated by x-ray films and ECG recordings was excellent. The duration of pacing with the lead was 4.3 days (mean) and ranged from 1 to 23 days, with episodes of capture failure in only seven cases. Two of these cases were readily corrected by repositioning. This new electrode system could be rapidly inserted with excellent stability and reliability for days. Its ease of use could expand the role of temporary atrial pacing.

Atrial Function↗

Pacemaker-mediated tachycardias: a rapid bedside technique for induction and observation.

The DDD pacemaker allows sensing and pacing in both chambers and can, therefore, maintain atrioventricular synchrony. However, this pacemaker creates an additional anterograde conduction system between the atrium and ventricle and, in the presence of ventriculoatrial (VA) conduction, the possibility of pacemaker-mediated tachycardia exists. A simple bedside technique that does not require catheterization or expensive equipment was used to detect VA conduction. Just after DDD pacer implantation, an attempt was made to detect VA conduction in 31 patients. Ambulatory monitoring (Holter) was done for 24 hours after implantation and at 2 to 4 and 6 to 8 weeks after implantation to detect pacemaker-mediated tachycardia. Attempts to induce pacemaker-mediated tachycardia were made using a special programmable external stimulator at follow-up after implantation. It was found that (1) all the 17 patients with detectable VA conduction had pacemaker-mediated tachycardia when the atrial refractory period was less than the VA conduction time, (2) pacemaker-mediated tachycardias were not inducible or detected spontaneously when atrial refractory period was equal to or greater than VA conduction time + 50 ms, (3) VA conduction was not detectable in 9 of the 17 patients at a later visit. Six of these 9 received antiarrhythmic therapy or had developed congestive heart failure. VA conduction has important implications in patients with DDD pacemakers and can be readily evaluated at the bedside.

Aged↗

The direct negative chronotropic action of prazosin on the canine sinus node.

The direct and indirect chronotropic effects of prazosin were studied in 22 anesthetized dogs using the technique of selective perfusion of the sinus node. Concentrations of 1, 10, 50 and 100 micrograms/ml of prazosin produced cumulative, dose-related reductions in mean sinus rat of 4 +/- 2; 10 +/- 6; 15 +/- 9 and 27 +/- 15 beats/min, respectively (P less than .0001). Intranodal prazosin did not significantly alter the positive chronotropic sinus node response to norepinephrine (0.05 and 0.1 micrograms/ml) administered via the same route. Sinus rate increases during stimulus frequency response curves after right stellate stimulation were not influenced by prior administration of prazosin. Sinus bradycardia elicited by submaximal vagal stimulation also was not affected by intranodal prazosin.l In six reserpinized dogs, methoxamine (10 and 25 micrograms/ml) injected into the sinus node artery caused a sinus rate increase of 10 4/- 2 and 14 +/- 3 beats/min (P less than .001). Intranodal prazosin (50 micrograms/ml) prevented this effect. Taken together, these results indicate that prazosin exerts a direct negative chronotropic action on the canine sinus node and that this effect is at least in part mediated through interference with alpha-1 receptors located in or near the sinus node. Prazosin has little or no effect on the presynaptic alpha-2 receptors nor does it interfere with the cholinergic mechanism in the sinus node.

Animals↗

Limited exercise testing soon after myocardial infarction. Correlation with early coronary and left ventricular angiography.

Forty-eight patients within 3 weeks of myocardial infarction underwent both limited treadmill graded exercise testing and coronary and left ventricular angiography. Nineteen (90%) of 21 patients with positive exercise tests (greater than or equal to 1 mm ST depression, angina, or both) had multivessel coronary artery disease. In the 27 patients with negative exercise test results, 15 (55%) had multivessel disease, 11 (41%) had single-vessel disease, and one (4%) had no coronary stenosis. Exercise-induced ST segment elevation occurred in 24 patients and predicted a significantly lower ejection fraction and higher angiographic abnormally contracting segment size. Patients experiencing angina during or after exercise had a significantly shorter 2-year survival (54% +/- 21%) than patients without exercise-induced angina (97% +/- 3%) (p less than 0.03). Thus limited exercise testing postinfarction is useful in evaluating the presence of multivessel coronary artery disease and left ventricular dysfunction and predicting long-term survival.

Adult↗